We sincerely thank the authors for their interest in our review entitled “From traditional to artificial intelligence-driven approaches: Revolutionizing personalized and precision nutrition in inflammatory bowel disease” and for their thoughtful comments. In addition, we appreciate the opportunity to clarify several aspects of our manuscript. First, regarding the section on artificial intelligence (AI), we agree that the current evidence supporting AI-driven nutritional decision-making in inflammatory bowel disease (IBD) remains limited and that prospective clinical validation studies are still needed. Anyway, our aim was not to show AI-based tools as established standards of care, but rather to discuss their emerging potential within the broader

Reply to: From traditional to artificial intelligence-driven approaches: Revolutionizing personalized and precision nutrition in inflammatory bowel disease / Baldi, S., Sarikaya, D., Lotti, S., Cuffaro, F., Fink, D., Colombini, B., Sofi, F., Amedei, A.. - In: CLINICAL NUTRITION ESPEN. - ISSN 2405-4577. - STAMPA. - 75:(2026), pp. 103450.103450-103450.103450. [10.1016/j.clnesp.2026.103450]

Reply to: From traditional to artificial intelligence-driven approaches: Revolutionizing personalized and precision nutrition in inflammatory bowel disease

Baldi, Simone
Writing – Original Draft Preparation
;
Lotti, Sofia
Writing – Original Draft Preparation
;
Cuffaro, Francesca
Writing – Original Draft Preparation
;
Fink, Dorian
Writing – Original Draft Preparation
;
Colombini, Barbara
Writing – Review & Editing
;
Sofi, Francesco
Writing – Review & Editing
;
Amedei, Amedeo
Writing – Review & Editing
2026

Abstract

We sincerely thank the authors for their interest in our review entitled “From traditional to artificial intelligence-driven approaches: Revolutionizing personalized and precision nutrition in inflammatory bowel disease” and for their thoughtful comments. In addition, we appreciate the opportunity to clarify several aspects of our manuscript. First, regarding the section on artificial intelligence (AI), we agree that the current evidence supporting AI-driven nutritional decision-making in inflammatory bowel disease (IBD) remains limited and that prospective clinical validation studies are still needed. Anyway, our aim was not to show AI-based tools as established standards of care, but rather to discuss their emerging potential within the broader
2026
75
103450
103450
Baldi, Simone; Sarikaya, Dilara; Lotti, Sofia; Cuffaro, Francesca; Fink, Dorian; Colombini, Barbara; Sofi, Francesco; Amedei, Amedeo
File in questo prodotto:
File Dimensione Formato  
PIIS2405457726005474.pdf

Accesso chiuso

Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 375.13 kB
Formato Adobe PDF
375.13 kB Adobe PDF   Richiedi una copia all'autore

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1499326
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact